NeuroPace GAAP EPS of -$0.08 beats by $0.08, revenue of $26.6M beats by $1.81M
Source: SeekingAlpha
2026-03-03 16:23:54 ET
More on NeuroPace
- NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- NeuroPace, Inc. (NPCE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- NeuroPace sees Q4 revenue of about $26.6M
- Seeking Alpha’s Quant Rating on NeuroPace
- Historical earnings data for NeuroPace
Read the full article on Seeking Alpha
For further details see:
NeuroPace GAAP EPS of -$0.08 beats by $0.08, revenue of $26.6M beats by $1.81M
Neuropace Inc.
NASDAQ: NPCE
NPCE Trading
1.3% G/L:
$14.415 Last:
78,208 Volume:
$14.17 Open:
NPCE Latest News
March 03, 2026 04:05:00 pm
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
NPCE Stock Data
$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
